0001209191-20-055435.txt : 20201020
0001209191-20-055435.hdr.sgml : 20201020
20201020204832
ACCESSION NUMBER: 0001209191-20-055435
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201016
FILED AS OF DATE: 20201020
DATE AS OF CHANGE: 20201020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beckman Daniella
CENTRAL INDEX KEY: 0001513422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39612
FILM NUMBER: 201249389
MAIL ADDRESS:
STREET 1: C/O IDENIX PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, BLDG. 1400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 5:01 Acquisition Corp.
CENTRAL INDEX KEY: 0001823465
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 852790755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: 415-993-8570
MAIL ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-16
0
0001823465
5:01 Acquisition Corp.
FVAM
0001513422
Beckman Daniella
C/O 5:01 ACQUISITION CORP.
501 SECOND STREET, SUITE 350
SAN FRANCISCO
CA
94107
1
0
0
0
Class B Common Stock
2020-10-16
4
J
0
30000
0.00
A
Class A Common Stock
30000
30000
D
The shares of Class B common stock are automatically convertible into the issuer's shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, and have no expiration date. The shares of Class B common stock are subject to forfeiture under certain circumstances relating to the Reporting Person's service on the issuer's Board of Directors.
In connection with the issuer's initial public offering and the Reporting Person's appointment to the issuer's Board of Directors, 5:01 Acquisition LLC transferred 30,000 shares of Class B common stock to the Reporting Person.
/s/ Nathan Jeffries, Attorney-in-Fact
2020-10-20